To examine the early cellular changes that accompany transformation, middle-T antigen (the transforming protein of polyomavirus), was expressed from an inducible promoter in Rat2 ®broblasts and in normal diploid human ®broblast (MRC5) cells using a replication defective adenovirus vector. The earliest detectable expression of middle-T antigen correlated closely with the initial changes in cellular morphology. At this time, expression of middle-T antigen resulted in the redistribution of shc and src to a brefeldin A resistant perinuclear compartment coincident with the formation of kinase active complexes containing middle-T antigen, shc and src. The ®rst detectable changes directly related to altered morphology was reorgnization of actin ®laments, and the condensation of tubular endosomes in the perinuclear region of the cell. These results suggest a potential role for perinuclear localized mT molecules in some of the morphologic changes associated with the initial phase of cellular transformation.
Introduction
The middle-T antigen (mT) of polyomavirus is sucient to transform a wide variety of cell lines as well as produce tumours in transgenic animals (Aguzzi et al., 1991; Grin and Dilworth, 1983; Rassoulzadegan et al., 1990; Treisman et al., 1981) and is a model system for studying many aspects of transformation (reviewed in Dilworth, 1995) . However, the role of mT in transformation has been determined almost exclusively in transformed or lytically infected cells and at a single time point (Andrews et al., 1993; Carmichael et al., 1982; Dilworth et al., 1986; Krauzewicz et al., 1994; Segawa and Ito, 1982; Zhu et al., 1984) . As a result, little is known about the initial changes that occur in cells expressing mT.
The protein is usually described as a membrane protein without intrinsic enzymatic activity (Andrews et al., 1993; Grin and Dilworth, 1983; Kaplan et al., 1988) . Although extensively studied, the site of mT membrane localization remains unresolved with morphologic studies favouring intracellular membranes (Dilworth et al., 1986; Templeton et al., 1984; Zhu et al., 1984) while biochemical analyses continue to be interpreted as suggesting that kinase active mT containing complexes are located at the plasma membrane (Ballmer-Hofer and Benjamin, 1985; Ito et al., 1977; Schahausen et al., 1982; Segawa and Ito, 1982) . Recently, we have demonstrated a role for cytoskeletal proteins, particularly actin, in the localization of mT (Andrews et al., 1993) . These results have been con®rmed and extended to suggest that mT may interact with the cytoskeleton at more than one location (Krauzewicz et al., 1994) . However, the role if any of these mT molecules at dierent subcellular locations has not been determined.
The evidence for membrane localization of mT includes co-fractionation with membranes in cell homogenates (Carmichael et al., 1982; Segawa and Ito, 1982) , release of the molecule from cells using non-ionic detergents (Krauzewicz et al., 1994) and the presence of an uninterrupted sequence of hydrophobic residues at the carboxyl terminus of the molecule (Carmichael et al., 1982) . Deletion of the hydrophobic carboxyl sequence prevents both correct sub-cellular localization of mT and transformation (Carmichael et al., 1982) . Similar hydrophobic sequences at the carboxyl ends of other proteins mediate insertion into membranes (Sabatini et al., 1982; Kutay et al., 1993) . Therefore, it is assumed that membrane insertion of the mT hydrophobic domain positions mT in the cell such that it can interact with binding proteins involved in transformation. These proteins include members of the src family of tyrosine kinases (Cheng et al., 1990a,b; Courtneidge and Smith, 1983; Horak et al., 1989; Kornbluth et al., 1987 Kornbluth et al., , 1990 Piwnica-Worms et al., 1990) , the proto-oncogene product shc (Campbell et al., 1994; Dilworth et al., 1994) , phosphatidyl inositol-3'-kinase Drucker et al., 1990) , protein phosphatase 2A (Dilworth and Horner, 1993; Pallas et al., 1990; Ulug et al., 1992) and isoforms of the 14-3-3 proteins .
We have used a Rat2 cell line in which mT expression can be induced and a replication defective adenovirus that encodes mT in the E1 region (Cook et al., 1990) to follow mT expression and morphologic transformation temporally. We report here that at early time points in both Rat2 cells and normal diploid human ®broblasts (MRC5 cells) a substantial fraction of the cellular mT is located in a perinuclear compartment that does not co-localize with marker proteins from either the endoplasmic reticulum or other sub-cellular compartments of the secretory pathway. Moreover, expression of mT at this location correlates with the initiation of a dramatic rearrangement of the actin cytoskeleton that is seen in transformed cells (Carley et al., 1981; Tucker and Sanford, 1978) and the dismantling of tubular endosomes, suggesting a role for perinuclear localized mT in some of the changes in morphology that accompany transformation. We also demonstrate that expression of mT relocates a substantial proportion of shc from the cytosol to the perinuclear compartment containing mT and that in mT expressing cells much of the src in the cells is also found in this compartment.
Results
Middle T is located in a perinuclear compartment at the onset of morphologic changes that precede full transformation
To examine the ®rst sub-cellular changes that occur after the expression of mT, we have used two dierent systems that allow control of expression of mT in virtually all of the cells: Rat2 cells using an inducible MMTV promoter and normal human ®broblasts (MRC5 cells) using an adenovirus vector. Estimates from immunoblots suggest that Rat2 cells expressing mT from the MMTV promoter (Rat2mT) express no more than two times as much mT as Rat2 cells expressing mT from its own promoter (data not shown). An advantage of using adenoviral vectors is that sucient mT is expressed in the infected MRC5 cells to permit biochemical characterization: at early times after infection (40 ± 45 h) MRC5 cells infected with an adenovirus vector expressing mT (Ad5/mT) express 5 ± 10 times more mT than Rat2mT cells (data not shown).
The MMTV promoter used to regulate the expression of mT in Rat2mT cells is almost completely shut o when cells are grown in medium containing phenol-red but supplemented with foetal calf serum depleted of endogeneous steroids by charcoal ®ltration.
In these cells morphology is normal (Figure 1a , upper panel) and mT is dicult to detect. However, a small amount of mT was observed in perinuclear structures using confocal laser scanning microscopy ( Figure 1a , lower panel). Expression of mT was increased in Rat2mT cells by growth in medium containing un®ltered serum, but cell morphology remained normal (Figure 1b, upper panel) . In these cells mT was clearly detected in perinuclear structures ( Figure  1b , lower panel). When dexamethasone was added to the medium the cells begin to change shape after 48 h (Figure 1c , upper panel) but large numbers of cells exhibiting the morphology of fully transformed cells were not observed until 72 h after induction (Figure 1d, upper panel) . At 48 h post-induction most of the mT is located in perinuclear structures (Figure 1c , lower panel) but is clearly more generally localized Figure 1 Localization of mT in Rat2mT cells. Confocal microscopy of Rat2mT cells grown in medium containing (a) charcoal ®ltered serum (uninduced) or (b) normal serum (low level expression) demonstrates that low levels of mT can be detected but are not sucient to transform cells in culture. (c) Induction with dexamethasone for 48 h reveals mT dependent changes in cell morphology during the early stages of transformation. (d) Morphological transformation is more advanced after 72 h. Rat2 cells were transfected with a plasmid encoding mT under the control of an MMTV promoter. A stable cell line that demonstrated an inducible transformed phenotype, designated Rat2mT was selected from the transfectants by standard procedures. At the indicated times or conditions Rat2mT cells were photographed by phase contrast microscopy (upper panels) or stained for mT using anity puri®ed polyclonal antibodies and visualized by staining with FITC labelled secondary antibodies. The width of the images in the top panels is approximately 240 mm and the bar in the lower panels indicates 10 mm Figure 2 Localization of mT and rG in cells co-stained for actin. Confocal microscopy of MRC5 cells demonstrates mT dependent changes in cell morphology during the early stages of transformation. MRC5 cells were infected with Ad5/mT or Ad5/rG and co-stained for either mT (using anity puri®ed polyclonal serum) or rG and visualized with FITC labelled secondary antibodies. Actin ®laments were visualized by staining with phalloidin conjugated with TRITC. (Figure 1d, lower panel) . Examination of the morphology of the cells stained for mT in the lower panels revealed that accumulation of mT in the perinuclear compartment correlated closely with the onset of morphology changes within individual cells (data not shown). Control experiments also demonstrated that the morphology changes were not observed in Rat2 cells grown similarly but not expressing mT (data not shown). Thus by examining Rat2/mT cells 48 h post-induction it is possible to investigate the mT mediated changes that precede the full acquisition of the morphological characteristics of transformed cells.
To examine the temporal relationship between mT expression and early changes in cell morphology in another system, MRC5 cells were infected with Ad5/ mT and then at various times post-infection the cells were co-stained for mT and actin and visualized using confocal laser scanning microscopy ( Figure 2 ). When MRC5 cells were infected with Ad5/mT signi®cantly more mT was expressed early after infection (40 h) than in the induced Rat2mT cells. As soon as cells express detectable amounts of mT they begin to acquire the morphological characteristics of transformed cells (Figure 2a ± d) . Comparison of the actin, tubulin and vimentin cytoskeletons in these cells revealed that actin staining was the most sensitive indicator of mT induced changes in morphology.
By 50 h post-infection all of the Ad5/mT infected cells are expressing relatively large amounts of mT, exhibit dramatically altered morphology and are becoming less adherent (Figure 2g ). The actin cytoskeleton has also condensed at the plasma membrane ( Figure 2h ) in structures typical of early changes in transformed cells (Carley et al., 1981; Tucker and Sanford, 1978) . Although a small amount of mT is observed at the plasma membrane of some Ad5/mT infected cells 50 h post-infection (data not shown), clear changes in actin distribution are seen in the majority of cells without detectable mT at the plasma membrane (as in Figure 2g ). Furthermore, mT is not routinely observed in the plasma membrane until 72 h post-infection (Figure 2i , arrowheads). At this time, the cells have acquired the`rounded' morphology of fully transformed cells and the actin cytoskeleton has become completely dismantled (Figure 2j ). Typically the morphology of the cytoskeleton is examined by solubilizing the cell with non-ionic detergent at low ionic strength and high glycerol concentration before ®xation. However, in our hands it was necessary to ®x the cells prior to solubilization in order to visualize both mT and actin in Ad5/mT infected cells. To determine if this re¯ected a mT dependent alteration speci®c to the actin cytoskeleton we compared the structure of both the actin and vimentin cytoskeleton using ®xation in our normal buer with that obtained by adding the ®xative after solubilization in an extraction buer known to stabilize cytoskeletal structures. When Ad5/mT infected cells were ®xed 40 h post-infection but before solubilization, mT, actin and vimentin were all easily visualized ( Figure 3a) .
As seen in Figure 2 , the actin cytoskeleton is completely re-arranged. However, the vimentin cytoskeleton is largely unaltered by the mT expressed in these cells (Figure 3a) . In contrast, when the cells were solubilized using the extraction buer prior to ®xation most of the mT and more than half of the actin is released from the cell. In contrast, the vimentin cytoskeleton remains intact when solubilization preceded ®xation (Figure 3b ). Control cells infected by a similar adenovirus vector that expressed the rabies virus G protein (Ad5/rG) exhibit normal cell morphology at 40 h post-infection (Figure 2e and f) that is maintained for these cells for at least 72 h (data not shown). The rabies virus G protein (Ad5/rG) is a well characterized membrane protein that is initially inserted into the endoplasmic reticulum and travels through the secretory pathway to the plasma membrane. As expected, both the actin and vimentin networks are unaltered by infection with the control virus Ad5/rG (Figure 3b ). Thus, we conclude that the The perinuclear compartment that contains mT is not part of the secretory pathway despite alterations seen in one of its components
In addition to the expected changes in the actin cytoskeleton, the late endosomal/trans-Golgi compartment was also altered early during the transformation process. In Rat2mT cells the mannose-6-phosphate receptor containing compartments gradually condensed beside the nucleus between 48 and 72 h after induction (Figure 4a ± c) . However, co-staining the cells for mT and mannose-6-phosphate receptor (Figure 4b and c) clearly demonstrated that mT is not located in this compartment. In uninfected MRC5 cells (Figure 5a ) or control cells expressing rabies virus G protein from Ad5/rG ( Figure 5c ) the characteristic structure of tubular endosomes was very evident when these cells are stained using the antibody to mannose-6-phosphate receptors (Brunetti et al., 1995) , and demonstrates that infection with the Ad5 construct does not by itself alter the morphology of this compartment. By contrast, similar to the Rat2mT cells, 40 h after infection of MRC5 cells with Ad5/mT, there was a clear reorganization of the tubular network into punctate structures concentrated in an eccentric perinuclear location (Figure 5b ). At this time point after infection mT is always present over a much larger area of the cell and the morphology of the mT containing compartment is quite dierent than that observed here. Thus in MRC5 cells the mT containing compartment is distinct from the tubular endosomes. Although all the cells selected were processed 40 h post-infection, the lower panel in Figure 5b illustrates the type of structure observed in a cell with slightly more advanced changes in morphology than the cell shown in the upper panel. This pattern did not resemble the location of mT at the same time point (Figure 2a and c) . At 40 h post infection with Ad5/mT the morphology of other compartments of the secretory pathway including endoplasmic reticulum, intermediate compartment, Golgi complex, Trans-Golgi network and Golgi (as indicated using an antibody to TGN38 to stain the rat2 cells) and secondary lysosomes were not altered by mT expression (Figures 6c and 8c , and data not shown).
Because of this disruption of a speci®c component of the secretory pathway, the well recognized association of mT with membranes (Carmichael et al., 1982) , and a previous report that mT is located in a perinuclear compartment that resembles the ER (Messerschmidt et al., 1996) , we investigated the relationship between mT and the secretory pathway using two dierent strategies. We co-stained for mT and calnexin (a luminal component of the endoplasmic reticulum), in cells 40 h after infection with Ad5mT, when mT is located in the perinuclear compartment (Figure 6a ± c, right panels). Despite looking at cells with dierent degrees of morphologic transformation, (minor Figure  6a and profound Figure 6b , left panels) we could not demonstrate similar localization of mT and calnexin at any stage. Furthermore, mT localization was not similar to marker proteins for other members of the secretory pathway, most of which were also sensitive to rearrangement by Brefeldin A, including Golgi complex (b-COP, Figure 6c ), endoplasmic reticulim Golgi intermediate compartment (ERGIC53, Figure 8c ), or late endosomes (data not shown).
In a second approach, we created a mT fusion protein targeted to the ER by replacing the mT hydrophobic carboxyl terminus with that from the ER isoform of rat cytochrome b5. We have previously demonstrated that this fusion protein inserts into microsomal membranes in vitro (Kim et al., 1997) and that a Bcl-2 fusion protein that contains the cytochrome b5 insertion sequence is speci®cally targeted to the ER in Rat ®broblasts, and is functional (Zhu et al., 1996) . However, Rat2 ®broblasts expressing the mT/cb5 fusion protein behind an inducible MMTV promoter did not display the early morphologic changes suggestive of transformation that we noted in mT expressing cells (Taylor, Zhu and Andrews, unpublished) .
Together the results shown in Figures 4 ± 6 and 8c suggest that one site of initial localization of mT is a non-secretory pathway perinuclear compartment and that mT moves to other sub-cellular locations as transformation proceeds. Before the cell has acquired the rounded morphology characteristic of a fully transformed cell the cytoskeleton and the tubular endosomal compartment undergo dramatic structural Figure 4 The mannose-6-phosphate receptor compartment condenses after induction of mT expression in Rat2mT cells. (a) Uninduced, (b) 48 h and (c) 72 h post induction, Rat2mT cells were stained with monoclonal antibodies to mT (left panels) and rabbit polyclonal antibodies to mannose-6-phosphate receptor (right panels). By 72 h post-induction the mannose-6-phosphate receptor containing compartment has completely condensed in an eccentric perinuclear location in almost all of the cells. The bar indicates 10 mm changes. To investigate the possibility that the perinuclear localized mT molecules play a role in some of these initial changes in cellular morphology, we examined the molecular interactions of mT known to be required for intracellular signalling.
Both shc and src are recruited to perinuclear brefeldin A resistant structures by expression of mT Transformation mediated by mT has been suggested to result from mT mimicking an activated growth factor Figure 5 The tubular endosomal compartment is altered early in the transformation process. (a) Uninfected MRC5 cells (b, c) MRC5 cells 40 h after infection with (b) Ad5/mT or (c) Ad5/rG were stained with antibody to the mannose-6-phosphate receptor, a marker of the late endosomal/trans Golgi network. In (a) and (c), this reticular structure is clearly visible as a perinuclear network that extends towards the periphery of the cell. (b) In cells expressing mT prominent punctate staining is consistently noted in an eccentric perinuclear location. The bar indicates 10 mm Figure 6 mT, calnexin and b-cop are not located in the same compartment at the onset of morphologic changes. MRC5 cells 40 h after infection with Ad5/mT were co-stained with antibodies mT (mT) and to calnexin (cal), a marker of the endoplasmic reticulum as indicated. Cells stained with calnexin antibody were selected that showed a minor (a), or profound degree (b) of morpholgic alteration. Both proteins are found in a perinuclear network, but the staining patterns are clearly dierent. Cells co-stained with mT and b-cop antibodies (c) were examined prior to (upper panels) and after treatment with Brefeldin A (lower panels). Brefeldin A rearranges b-COP, but does not change the localization of mT. The bar indicates 10 mm receptor (Dilworth et al., 1994) . Consistent with this view, the molecules previously shown to bind mT have been linked to signal transduction. To determine if these interactions are occurring at the onset of transformation we examined sub-cellular localization for two of these mT binding proteins (shc and src) as binding of both shc and src are essential for the full expression of mT mediated transformation (Blaikie et al., 1997; Brewster et al., 1997; Yi et al., 1997) and both molecules have been linked to signal transduction (Egan et al., 1993; Rozakis-Adcock et al., 1992) .
When uninduced Rat2mT cells were co-stained for mT and shc (Figure 7a ) shc was observed in the cytoplasm as expected, but a fraction of the endogeneous shc molecules also co-localized with the small amount of mT expressed in these cells. When mT expression was induced for 48 h both mT and shc were clearly observed in perinuclear structures (Figure 7b ). Not all of the shc was relocated to the perinuclear compartment as some shc was still detected in the cytosol out to the plasma membrane (Figure 7b , arrowheads). In uninduced cells co-stained for mT and src, src was found associated with intracellular membranes (Figure 7c ) and plasma membrane ( Figure  7c , arrowhead), as expected. In contrast, both mT and src were located in perinuclear structures after induction (Figure 7d ). The overlap in the distributions is not exact suggesting that not all of the src or shc is bound directly to mT. Moreover, the amount of shc and src recruited to this compartment was greater than expected based on previous co-immunoprecipitation assays. Examination of single sections through the centre of the cells by confocal microcroscopy con®rmed that the concentration of src and shc observed in the perinuclear region resulted from redistribution of the molecules rather than from increased thickness of this region of the cell. Thus one early function of mT is to redistribute src and shc to perinuclear structures.
Experiments using either uninfected (data not shown) or MRC5 cells infected with Ad5/rG ( Figure  8a ), revealed that shc is normally localized primarily to the cytoplasm. However, at 40 h post-infection with Ad5/mT, slides co-stained for mT and shc revealed extensive overlap in the distributions of the molecules suggesting that similar to the relocation of shc that occurs upon induction of mT expression in Rat2/mT cells, most of the normally cytoplasmic shc was relocated to the perinuclear compartment containing mT 40 h after infection with Ad5/mT (Figure 8b and  d) . Although in Ad5/mT infected MRC5 cells it appeared that the endogeneous src was also relocated to the perinuclear mT containing compartment, the comparatively small amount of endogeneous src in MRC5 cells made determination of co-localization with mT expressed in the cells after infection with Ad5/mT dicult (data not shown). To obtain roughly equivalent amounts of src and mT in micrographs of MRC5 cells, the cells were co-infected with Ad5/src and Ad5/mT. Control experiments demonstrated that consistent with previous reports with other cell types, in cells infected with Ad5/src (data not shown) or cells co-infected with Ad5/src and Ad5/rG ( Figure 8a ) the src was found in a variety of sub-cellular membranes. Unlike mT however, expression of src did not alter the morphology of the infected cells. Co-staining experiments for MRC5 cells infected with Ad5/mT and Ad5/ src revealed extensive overlap in the distributions of src and mT (Figure 8b and d) . Furthermore, treatment of cells with brefeldin A relocalized the marker for the endoplasmic reticulum/Golgi intermediate compartment ERGIC-53 (Figure 8c ) as expected (LippincotSchwarz et al., 1990 ), but did not alter the distribution for mT, nor was the extensive co-localization of shc and src with mT perturbed (Figure 8d ). Although the relocation of shc and src in Ad5/mt infected cells is stunning and clearly indicates that shc, src and mT are located in the same brefeldin A resistant subcellular compartment, the micrographs cannot demonstrate direct binding of mT to src or shc.
Evidence for tyrosine kinase active mT, src, shc complexes in Ad5/mT infected cells
Since mT associated tyrosine kinase activity is essential for cellular transformation we examined the mT containing perinuclear structures for phosphotyrosine by co-staining the Rat2mT cells with either PY-20 monoclonal (Figure 7e and f) or polyclonal antiphosphotyrosine antibodies (data not shown). In cells induced with dexamethasone, phosphotyrosine clearly co-localized with mT in perinuclear structures. This result suggests that expression of mT in Rat2 cells leads to increased tyrosine kinase activity in these perinuclear structures. To determine if, similar to Rat2mT cells, tyrosine kinase activity was present in the perinuclear mT containing structures in MRC5 cells these cells were co-stained for mT and phosphotyrosine. As expected from the results obtained with Rat2mT cells (Figure 7e and f) , infection with Ad5mT Figure  9a right hand panel) . Phosphotyrosine is also seen in the periphery of Ad5/mT infected cells at 40 h postinfection. Thus as expected, not all of the phosphotyrosine in the cell was located in the perinuclear mT containing structures. Nevertheless, our data strongly suggests that the perinuclear mT containing compartment of Ad5/mT infected cells contains tyrosine kinase activity.
The re-organization of shc in Ad5/mt infected cells shown in Figure 8 , was suciently dramatic to suggest that it should also be detectable in sub-cellular fractionation experiments. In uninfected MRC5 cells, most of the shc is not pelleted by centrifugation at 100 000 g and is recovered primarily in the S100 (cytosolic) fraction (Figure 10a ). However, in Ad5/ mT infected cells, the amount of shc recovered with mT in 100 000 g pellets of homogenized cells (P100 fraction) increased when the amount of mT expressed in the cells increased (Figure 10a ). This result con®rms that the shc molecules are redistributed in the cell rather than passively accumulating in the perinuclear region simply because of the change in the shape of the cell.
Previously, we demonstrated that mT can be released from P100 fractions prepared from late stage Ad5/mT infected 293 cells and from transformed rat ®broblasts in large complexes containing actin (Andrews et al., 1993) . Using similar methods, the P100 fraction of Ad5/mT infected MRC5 cells was fractionated by solubilization with non-ionic detergent at low ionic strength and centrifugation to pellet the cytoskeleton (C). Phase partitioning of the remaining soluble material yielded a fraction containing short actin ®laments that was previously assumed to originate primarily from the sub-membraneous cytoskeleton (M), as well as fractions containing aqueous soluble proteins (mostly lumenal contents) (A) and hydrophobic membrane proteins (D) (Figure 10b ) (Andrews et al., 1993) . At 40 h post-infection with Ad5/mT, shc was recovered almost exclusively in the fraction containing cytoskeleton (Figure 10b ). In addition to the three reported shc isoforms of 66, 52 and 46 kDa we observed an additional band (indicated by the arrowhead in Figure 10b ) that migrated at 58+/ 2 kDa (average of four determinations). Although a similar sized band was also observed in cytosol prepared from uninfected cells, this species was most evident in the cytoskeleton fraction of cells expressing mT. The origin of this species was not investigated and it may result from degradation of the 66 kDa species. Alternatively, it may result from a post-translational modi®cation of shc similar to that shown previously to correlate with mT mediated transformation of NIH3T3 cells (Campbell et al., 1994) . Nevertheless the dramatic change in fractionation of shc (from cytosol to a detergent insoluble fraction enriched in cytoskeleton) is consistent with the recruitment of shc to a new compartment due to mT expression con®rming our observations in Figure 8 . Furthermore, in contrast with our previous results (Andrews et al., 1993) , more than half of the mT was also recovered from this fraction.
Phase partitioning of the detergent soluble material permits direct comparison of the behaviour of mT at the onset of transformation with that we published previously for fully-transformed Rat2 cells and late stage infections of 293 cells with Ad5/mT. In our previous experiments most of the mT co-fractionated with short actin ®laments and elements of the membrane skeleton whilst only a small amount of mT co-fractionated with the contractile cytoskeleton (Andrews et al., 1993) . In contrast in Ad5/mT infected MRC5 cells, at 40 h post-infection most of the mT was found in the cytoskeleton enriched fraction. Nevertheless even at this early timepoint some of the mT was also found in fraction M (previously shown to contain short actin ®laments). Signi®cantly, 50 h after Ad5/mT infection of MRC5 cells, more mT was recovered from fractions containing short actin ®laments than was found in this fraction 40 h after infection (Figure 10b ) suggesting a temporal relationship. Therefore, it is likely that in our previous study the mT recovered with short actin ®laments in transformed Rat2 cells was the result of disassembly of the contractile cytoskeleton into fragments that co-fractionate with the submembraneous cytoskeleton. Phase partitioning cannot be used to assay mT interaction with src as the interaction between these molecules is disrupted and src is found exclusively in the detergent fraction, presumably because of the myristate at the amino terminus (Andrews et al., 1993) .
Together these results demonstrate that at the onset of transformation mT recruits shc to structures with the unusual solubility properties of cytoskeleton at a time when the actin cytoskeleton is being dramatically reorganized (Figures 1 ± 3 ). This localization is Figure 10 Western blots of fractions prepared from MRC5 cells reveal that infection with Ad5/mT relocalizes shc from the cytoplasm to cytoskeleton associated structures. (a) Mock infected cells (infection 0) and two dierent infections with Ad5/mT (infection 1,2) were homogenized and divided into two fractions: S, 100 000 g supernatant-cytosol; P, 100 000 g pellet, electroblotted on nitrocellulose and probed for shc. Inset, a blot of the same samples probed with mT antibodies to show the mT in P100 fractions from the same infections. (b) Phase partitioning of the 100 000 g pellets from MRC5 cells infected with Ad5/mT for the indicated times into fractions containing: C, cytoskeleton; A, aqueous soluble proteins; M, sub-membraneous cytoskeleton; D, detergent soluble hydrophobic proteins. The arrowhead indicates the`extra' shc band described in the text. The antigen recognized by the primary antibodies used to probe the blots is indicated to the right of the relevant bands. Equal numbers of cell equivalents were loaded in each lane. Blots were probed with secondary antibodies coupled to alkaline phosphatase and developed colorimetrically compatible with recent data demonstrating binding of mT to cytoskeleton (Krausewcz et al., 1994) . However, our results do not demonstrate that the src or shc molecules recruited to the perinuclear compartment are necessarily bound to mT. It is possible that in response to mT mediated signalling shc and src molecules are recruited to the mT containing compartment independent of mT binding.
Functional complexes of mT, shc and src are kinase active due to the interaction of mT with src (Courtnedge and Smith, 1983; Piwnica-Worms et al., 1990) . After induction of the Rat2mT cells and in Ad5mT infected MRC5 cells, the perinuclear mT containing structures are enriched in phosphotyrosine (Figures 7 and 8) . To determine if kinase active complexes of mT, src and shc exist in Ad5/mT infected MRC5 cells, P100 fractions were solubilized with NP40 and mT, src and shc immunoprecipitates were assayed for kinase activity ( Figure 11 ). As expected mT immunoprecipitates of cells infected with Ad5/mT for 40 h are kinase active and mT precipitable kinase activity is increased by co-infection with Ad5/ src.
Consistent with complex formation, kinase activity can also be precipitated with antisera to either src or shc (Figure 11) . Therefore, mT, src and shc form kinase active complexes in Ad5/mT infected MRC5 cells at the onset of morphologic transformation. The major phosphotyrosine containing substrate of the mT activated src kinase in these immunoprecipitates migrates at 60 kDa. Consistent with this band being due to phosphorylation of src, immunoprecipitation with an antiphosphotyrosine monocloal antibody PY20 followed by Western blotting with antiserum to src con®rmed that src is tyrosine phosphorylated in these cells (data not shown).
The mitogenic response of cells to mT expression requires activation of the src kinase. Furthermore, binding of shc by mT is believed to link mT to the activation of ras necessary for mT mediated transformation (Jelinek and Hassell, 1992) . Therefore, relocalization of src and shc to the perinuclear mT containing compartment in Rat2mT and Ad5/mT infected MRC5 cells (Figures 7 and 8 ) together with the demonstration that this region of the cell is enriched in phosphotyrosine (Figures 7 and 9 ) and that kinase active mT/shc/src complexes are present 40 h post-infection with Ad5/mT (Figure 11) suggests that some mT mediated signalling occurs from the perinuclear compartment.
Discussion

Early changes in cell morphology mediated by mT
When mT is ®rst detected after induction of expression in Rat2mT cells or after Ad5/mT infection of MRC5 cells, staining is con®ned to the perinuclear region of the cell (Figures 2, 3 and 6 ± 8) . Localization of mT within the cell interior has been observed previously (Dilworth et al., 1986; Zhu et al., 1984; Messerschmidt et al., 1996) . However, in these studies cellular morphology with respect to the early events in transformation and the site of initial sub-cellular location of mT were not analysed in detail.
In our studies, we have noted that the earliest morphology changes due to expression of mT were the reorganization of the actin cytoskeleton particularly evident in MRC5 cells (Figures 2 and 3 ) and the condensation of the mannose-6-phosphate receptor containing sub-cellular compartment observed in both Rat2mT cells and Ad5/mT infected MRC5 cells (Figures 4 and 5) . Although reorganization of one or more components of the cytoskeleton was expected to be an early event, condensation of tubular endosomes was unanticipated. It is not clear what role this dramatic reorganization of subcellular membrane could play in oncogenic transformation. However, many of the eects of mT on cellular structure and metabolism have proven to be general features of transformed cells. Thus we predict that reorganization of the endocytic pathway accompanies transformation in at least some other systems. If our prediction is correct then it will be important to determine whether reorganization of the endocytic compartment contributes to or is a consequence of transformation.
Reorganization of the actin cytoskeleton and the endocytic compartment both occurred while a substantial fraction of mT was located in perinuclear structures. Sub-fractionation of the cells (Figure 10 ) and co-precipitation data (Figure 11 ) also suggest that mT in this compartment is in kinase active complexes containing mT, shc and src (Figures 7 and 9 ). Together these results suggest an active role for the perinuclear localized mT molecules in alterations in cellular morphology at the onset of transformation. Nevertheless, it will be necessary to de®ne more precisely the perinuclear structures observed here in order to determine what role perinuclear localized mT molecules have in transformation.
Earlier results have suggested that intracellular mT is located in endoplasmic reticulum or Golgi structures (Zhu et al., 1984; Messerschmidt et al., 1996) . However, examination of induced Rat2mT cells at the onset of morphology changes or MRC5 cells 40 h Figure 11 Kinase activity is immunoprecipitable with antibodies to mT, src or shc from MRC5 cells infected with Ad/5mT or coinfected with Ad5/mT and Ad5/src. Cells were lysed, antibodies added as indicated and immunoprecipitates were prepared using protein A/G Sepharose. The immunoprecipitates were assayed for kinase activity by adding [g-32 P]ATP (5.0 mCi per reaction) and MnCl 2 (to 10 mM) and incubating at 308C for 5 min. After separation by SDS ± PAGE radioactivity was recorded using a phosphorimager after infection with Ad5/mT revealed no co-localization of mT with either the ER marker calnexin or the Golgi marker b-COP (Figure 6 ). Furthermore, cells expressing a fusion protein in which mT was targeted to ER did not show any morphologic changes suggestive of transformation (data not shown). Thus we conclude that the perinuclear structures do not arise from mT induced reorganization of the ER.
The observed localization for mT also does not resemble that of tubular endosomes (Figures 4 and 5) , or Golgi (Figure 6 ). Moreover, unlike the Golgi, and ER-Golgi intermediate compartment (ERGIC) the site of mT localization is not altered by the drug brefeldin A (Figure 8) . Therefore, we ®nd no evidence for mT within the conventional secretory pathway and have not been able to identify the mT containing perinuclear compartment.
Mechanism of middle-T mediated transformation
Although the cell cycle control activity of polyomavirus Large T antigen is required for transformation of many primary cells in culture, mT alone is sucient to eciently transform Rat2 cells. In the Rat2mT cells used here, induction of mT expression with dexamethasone leads to features associated with transformation other than the well-recognized morphologic changes: reduced doubling time, reduced requirement for serum in the medium, and growth of colonies in semi-solid medium (data not shown). All these features are consistent with mT mediating several aspects of mitogenic and morphologic transformation in these Rat2 cells. While we have not formally demonstrated that mT initiates these changes from the perinuclear compartment, it is likely that signalling via shc and src molecules bound to mT at this site contributes to the early alterations in cellular morphology observed. Consistent with this possibility, we (Figures 2 ± 4, 10, 11 and Andrews et al., 1993) and others (Krauzewicz et al., 1994) have described the association of mT with cytoskeletal elements, and shc and src SH2 domains (and the SH3 domain in src) can mediate direct interactions with cytoskeletal proteins (Mayer and Baltimore, 1993; Okamura and Resh, 1994) . Thus it is possible that mT mediates some cytoskeletal rearrangements via interactions with these molecules from the perinuclear location. Furthermore, the insertion of mT into the relevant membrane that is necessary for transformation may be dependent upon the interaction of the mT complex with cytoskeletal elements (Andrews et al., 1993; Kim et al., 1997) .
The accumulation of phosphotyrosine suggests that mitogenic signalling may be occurring at these perinuclear structures. The interaction of mT with src and shc suggests that mT mediated transformation parallels the mechanism of signal transduction by receptor tyrosine kinases (Dilworth et al., 1994) . Although most growth factor receptor mediated signalling events are believed to occur at the plasma membrane, there is evidence from several receptor systems that mitogenic signal transduction events occur at intracellular membranes. Transmembrane signalling via the kinase activity of the insulin receptor has been shown to be initiated in an endosomal compartment before recycling to the plasma membrane by a microtubule dependent process (Bevan et al., 1995) . Activation of the EGF receptor in rat liver parenchyma by extracellular EGF has been reported to lead to endocytosis of the receptor, activation of the receptor tyrosine kinase and recruitment of shc to an intracellular EGF receptor containing compartment (Di Guglielmo et al., 1994) . Moreover, the control of membrane tracking of the EGF receptor can dierentially regulate the various second messengers involved in signal transduction (Viera et al., 1996) . Similarly, in transformed ®broblasts over-expressing shc, EGF stimulation recruits shc to both endosomes and the plasma membrane (Lotti et al., 1996) . EGF receptor signalling has also been linked to binding of the actin cytoskeleton (Den Hartigh et al., 1992) . Therefore, there is precedent for growth factor receptor signalling from non-plasma membrane locations.
An intriguing parallel exists between mT mediated relocalization of shc and src and the mechanism of a re-directed signalling resulting in transformation proposed for bcr ± abl. In the latter case, the formation of a hybrid protein by the t(9;22) chromosomal translocation results in the activation of a cryptic actin-binding site in the carboxyl region of abl. This actin binding sequence re-directs the bcr ± abl fusion protein from the nucleus to the cytoplasm. Moreover, mutations in the actin binding sequence of the fusion protein that do not prevent cytosolic localization of the bcr ± abl protein greatly reduce transformation (McWhirter and Wang, 1993) . Similar to mT mediated transformation, transformation by bcr ± abl requires both phosphotyrosine binding to shc that mediates activation of Ras (Tauchi et al., 1994) and activation of PI3 kinase (Urich et al., 1995; Skorski et al., 1997) . Although actin binding is implicated in both transformation processes it remains to be determined if signalling by the bcr ± abl protein occurs from the same intracellular compartment as mT. Future attempts to understand these processes will require a more precise identi®cation and puri®cation of this subcellular compartment.
Materials and methods
Biological reagents
Embryonal human kidney ®broblast (MRC5) cells and human kidney cells (293 N3S) transformed with the early region of adenovirus were provided by F Graham, McMaster University. Recombinant adenovirus expressing mT (Ad5/mT) and src (Ad5/src) were provided by J Hassell, McMaster University. A recombinant adenovirus expressing glycoprotein G from rabies virus was provided by L Prevec, McMaster University. Viruses were propagated in 293 N3S cells by infection at 100 p.f.u./cell. Virus stocks were prepared by harvesting cell culture medium 48 ± 72 h post-infection. A construct expressing mT (or modi®ed to express a mT-cytochrome b5 fusion protein (Kim et al., 1997 ) from a highly regulated version of MMTV promoter kindly provided by Dr William Muller, McMaster University was transfected into Rat2 cells and stable cell lines were selected in G418 and passaged by standard means.
Polyclonal antiserum to mT was generated using a GSTmT fusion protein containing amino acids 176 ± 393 of mT. Anity puri®ed antiserum was obtained by sequential chromatography of the rabbit serum on columns containing immobilized GST and GST-mT. Culture media containing the mT monoclonal antibodies 421 and 422 (Grin and Dilworth, 1983) as well as 721 and 722 (Dilworth and Horner, 1993) 
Immuno¯uorescence
Cells cultured in a-MEM supplemented with 10% foetal calf serum, penicillin and streptomycin were plated on glass coverslips 24 ± 36 h before infection and grown until they covered almost half of the dish. Approximately 100 p.f.u./ cell of the desired recombinant adenovirus was added to the cell culture medium for 45 min at 378C and then the medium was exchanged for a-MEM containing 2% horse serum. To permit comparison of dierent markers with equivalent adenovirus infections, multiple coverslips were processed in the same 100 mm dish. To examine subcellular changes induced by brefeldin A, the drug was added to cell cultures at a ®nal concentration of 5 mg/ml for 45 min prior to processing for immuno¯uorescence. As positive controls, uninfected cells were treated with brefeldin A and stained with antibodies to b-COP in each experiment.
Before labelling, the coverslips were transfected to six-well plates, washed twice with phosphate-buered saline (PBS) and ®xed for 30 min in 4% paraformaldehyde. After washing once with PBS, the cells were permeabilized by incubation for 10 min in PBS containing 1% Triton X-100 and washed with PBS containing 0.02% Tween 20. Non-speci®c binding sites were blocked by incubation in PBS containing 1% bovine serum albumin and 0.02% Tween 20. For labelling, the permeabilized cells were incubated for 1 h at 378C in PBS containing 3% bovine serum albumin and puri®ed primary antibodies or serum. In some experiments the mT polyclonal serum was ®rst depleted for potential cross-reacting species by incubation with permeabilized non-infected or untransfected cells overnight at 48C. After washing for 5 min in PBS containing 1% bovine serum albumin and 0.02% Tween 20 at room temperature, the coverslips were incubated in PBS containing 3% bovine serum albumin and the appropriate secondary antibody. To visualize actin ®laments, coverslips containing permeabilized cells were incubated with TRITCconjugated phalloidin (0.1 mM) in PBS containing 3% bovine serum albumin for 60 min at 378C. After staining, unbound antibodies or phalloidin were removed by sequential 5 min washes in PBS containing 0.02% Tween 20 and PBS alone. The specimens were dried by incubation at 378C for 45 min and mounted for microscopy in a solution containing 80% glycerol and 2.5% Dabco in PBS. The extraction buer used to examine cytoskeleton integrity was as described (Bar-Sagi et al., 1993) . Control experiments demonstrated negligible staining with secondary antibodies alone.
Immuno¯uorescence images were recorded using a confocal laser scanning microscope (Carl Zeiss BIOMED LSM 10). To provide a clear view of the cell interior, optical sections collected beginning near the bottom of the nucleus and ending near the top of the nucleus were summed. For photography the images were processed using Adobe Photoshop and printed using a Techtronix phaser printer.
Sub-cellular fractionation
Sub-cellular fractions were prepared as described previously (Andrews et al., 1993) . Brie¯y, after homogenization in a hypotonic buer containing protease inhibitors, the nuclei, cellular debris and unbroken cells were removed by centrifugation at 1000 g for 5 min. Sub-cellular structures (membrane vesicles and cytoskeleton) were then separated from cytosol by centrifugation at 100 000 g for 1 h. The resulting supernatant (S100) fraction containing primarily cytosolic proteins was frozen in liquid nitrogen and stored at 7808C. The pellet fraction (P100) was resuspended in 50 mM triethanolamine pH 8.0 containing 250 mM sucrose as cryoprotectant and frozen in liquid nitrogen. For phase separation of the P100 fraction a previously described modi®cation (Andrews et al., 1993) of the Triton X-114 technique originally devised by Bordier (1981) was used. After separation by SDS ± PAGE speci®c proteins were identi®ed in the fractions by immunoblotting. Secondary antisera, coupled to alkaline phosphatase, were visualized using a colorimetric reaction with nitroblue terazolium chloride and 5-bromo-4-chloro-3-indolylphosphate p-toluidine (Life Technologies, Burlington, Canada). To provide a permanent record of the data, blots were digitized using a¯atbed scanner and printed as above. The relative amounts of a single protein identi®ed on the same blot using one primary antibody were estimated visually from the original blots. Kinase assays were performed as described previously (Andrews et al., 1993) .
